Azulfidine: Effective Control for Inflammatory Bowel Disease
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.97 | $58.06 (0%) | 🛒 Add to cart |
| 90 | $0.86 | $87.08 $77.07 (11%) | 🛒 Add to cart |
| 120 | $0.81 | $116.11 $97.09 (16%) | 🛒 Add to cart |
| 180 | $0.75 | $174.17 $134.13 (23%) | 🛒 Add to cart |
| 270 | $0.72
Best per pill | $261.25 $193.19 (26%) | 🛒 Add to cart |
Synonyms | |||
Azulfidine (sulfasalazine) is a time-tested, prescription medication primarily used to manage and maintain remission in ulcerative colitis and rheumatoid arthritis. It belongs to the class of drugs known as aminosalicylates and works by reducing inflammation in the colon and joints. This medication is a cornerstone therapy for many patients, offering a balance of efficacy and a well-understood safety profile when monitored appropriately. It is available in both standard and delayed-release formulations to suit individual patient needs and treatment goals.
Features
- Contains sulfasalazine as the active pharmaceutical ingredient
- Available in 500 mg oral tablets, including enteric-coated options
- Combines anti-inflammatory and antibacterial properties through its metabolic products
- Requires a prescription and regular medical supervision
- Manufactured under strict pharmaceutical quality control standards
Benefits
- Effectively reduces inflammation in the colon, leading to symptom relief in ulcerative colitis
- Helps induce and maintain remission, preventing disease flares
- Can improve joint pain, swelling, and stiffness in rheumatoid arthritis
- Long-term use may reduce the need for corticosteroid therapy
- Well-established in clinical practice with decades of real-world evidence
- Offers a cost-effective treatment option compared to newer biologics
Common use
Azulfidine is primarily indicated for the treatment of mild to moderate ulcerative colitis and for the management of rheumatoid arthritis in patients who have responded inadequately to first-line therapies. It is often used as a first-line maintenance therapy for ulcerative colitis to prevent relapse. In rheumatology, it is frequently part of disease-modifying antirheumatic drug (DMARD) regimens, either as monotherapy or in combination with other agents.
Dosage and direction
For ulcerative colitis in adults: Initial dose is 1-2 g daily in divided doses, gradually increasing to a maintenance dose of 2-4 g daily in divided doses. Maximum dose is 4 g daily. For rheumatoid arthritis: Start with 500 mg daily, increasing weekly to a maintenance dose of 2-3 g daily in divided doses. Tablets should be swallowed whole with a full glass of water after meals to minimize gastrointestinal upset. Regular blood tests are required during treatment.
Precautions
Patients should have complete blood counts, liver function tests, and renal function tests before starting therapy and regularly during treatment. Maintain adequate fluid intake (at least 6-8 glasses of water daily) to prevent crystalluria and stone formation. Use with caution in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency due to hemolysis risk. May cause orange-yellow discoloration of urine and skin, which is harmless. Sun exposure should be limited due to increased photosensitivity.
Contraindications
Hypersensitivity to sulfonamides, salicylates, or any component of the formulation; intestinal or urinary obstruction; porphyria; children under 2 years of age; pregnancy at term and during breastfeeding; severe liver or kidney impairment.
Possible side effect
Common: Nausea, vomiting, headache, loss of appetite, reversible oligospermia. Less common: Skin rash, fever, hepatitis, hemolytic anemia. Rare but serious: Stevens-Johnson syndrome, toxic epidermal necrolysis, agranulocytosis, aplastic anemia, drug-induced lupus. Most side effects are dose-related and may diminish with continued therapy or dose reduction.
Drug interaction
May enhance effects of oral hypoglycemics, warfarin, and methotrexate. Reduces absorption of digoxin and folic acid. Probenecied may increase sulfasalazine levels. Antibiotics may alter gut flora and affect drug metabolism. Concurrent use with other hepatotoxic drugs increases liver injury risk.
Missed dose
If a dose is missed, take it as soon as remembered unless it is nearly time for the next dose. Do not double the dose to make up for a missed one. Maintain regular dosing schedule to ensure consistent therapeutic effect. Contact healthcare provider if multiple doses are missed.
Overdose
Symptoms may include nausea, vomiting, abdominal pain, drowsiness, convulsions. Massive overdose may cause hemolytic anemia, methemoglobinemia, and hepatic necrosis. Treatment is supportive and symptomatic. Gastric lavage may be beneficial if performed soon after ingestion. Hemodialysis is not effective due to high protein binding.
Storage
Store at room temperature (15-30°C) in original container, protected from light and moisture. Keep tightly closed and out of reach of children. Do not use after expiration date. Do not transfer to other containers as moisture protection may be compromised.
Disclaimer
This information is for educational purposes only and does not replace professional medical advice. Always consult with a qualified healthcare provider for diagnosis and treatment decisions. Dosage and indications may vary based on individual patient factors. The prescriber should be familiar with the complete prescribing information before initiating therapy.
Reviews
Clinical studies demonstrate Azulfidine’s efficacy in maintaining remission in approximately 60-80% of ulcerative colitis patients when used appropriately. Rheumatology trials show significant improvement in joint symptoms and disease activity measures. Many patients report improved quality of life with long-term therapy, though some note gastrointestinal side effects during initial treatment phase. Regular monitoring is consistently emphasized as crucial for safe, effective use.